Global Oligonucleotide Therapeutics Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	169 Pages	TechNavio	April, 2024	INF18746353

Best Price Guarantee
Price	from $2,500
Length	169 Pages
Publisher	TechNavio
Published Date	April, 2024
SKU	INF18746353

Global Oligonucleotide Therapeutics Market 2024-2028

The oligonucleotide therapeutics market is forecasted to grow by USD 13443.7 mn during 2023-2028, accelerating at a CAGR of 19.87% during the forecast period. The report on the oligonucleotide therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of cancer boosts demand for novel diagnostics, need for personalized medicines for neurological disorders, and increasing availability of oligonucleotide therapeutic drugs.

Technavio's oligonucleotide therapeutics market is segmented as below:

By Type

Antisense oligonucleotides
RNA interference
Aptamers and others

By Application

Neurological
Cancer
Infectious diseases and others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advances in DNA sequencing increasing adoption of microfluidic techniques as one of the prime reasons driving the oligonucleotide therapeutics market growth during the next few years. Also, high market growth potential in developing economies and growing adoption of artificial intelligence for disease evaluation will lead to sizable demand in the market.

The report on the oligonucleotide therapeutics market covers the following areas:

Oligonucleotide therapeutics market sizing
Oligonucleotide therapeutics market forecast
Oligonucleotide therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading oligonucleotide therapeutics market vendors that include Agilent Technologies Inc., Alnylam Pharmaceuticals Inc., Biogen Inc., CSL Ltd., GlaxoSmithKline Plc, Ionis Pharmaceuticals Inc., Maravai LifeSciences Holdings Inc., Merck KGaA, Nippon Shinyaku Co. Ltd., Novartis AG, Pfizer Inc., Sarepta Therapeutics Inc., and Thermo Fisher Scientific Inc.. Also, the oligonucleotide therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Executive Summary
- Market overview
  - Table Executive Summary – Chart on Market Overview
  - Table Executive Summary – Data Table on Market Overview
  - Table Executive Summary – Chart on Global Market Characteristics
  - Table Executive Summary – Chart on Market by Geography
  - Table Executive Summary – Chart on Market Segmentation by Type
  - Table Executive Summary – Chart on Market Segmentation by Application
  - Table Executive Summary – Chart on Incremental Growth
  - Table Executive Summary – Data Table on Incremental Growth
  - Table Executive Summary – Chart on Vendor Market Positioning
Market Landscape
- Market ecosystem
  - Table Parent market
  - Table Market Characteristics
Market Sizing
- Market definition
  - Table Offerings of vendors included in the market definition
- Market segment analysis
  - Table Market segments
- Market size 2023
- Market outlook: Forecast for 2023-2028
  - Table Chart on Global - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Global - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Global Market: Year-over-year growth 2023-2028 (%)
  - Table Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Historic Market Size
- Global oligonucleotide therapeutics market 2018 - 2022
  - Table Historic Market Size – Data Table on global oligonucleotide therapeutics market 2018 - 2022 ($ million)
- Type Segment Analysis 2018 - 2022
  - Table Historic Market Size – Type Segment 2018 - 2022 ($ million)
- Application Segment Analysis 2018 - 2022
  - Table Historic Market Size – Application Segment 2018 - 2022 ($ million)
- Geography Segment Analysis 2018 - 2022
  - Table Historic Market Size – Geography Segment 2018 - 2022 ($ million)
- Country Segment Analysis 2018 - 2022
  - Table Historic Market Size – Country Segment 2018 - 2022 ($ million)
Five Forces Analysis
- Five forces summary
  - Table Five forces analysis - Comparison between 2023 and 2028
- Bargaining power of buyers
  - Table Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
- Bargaining power of suppliers
  - Table Bargaining power of suppliers – Impact of key factors in 2023 and 2028
- Threat of new entrants
  - Table Threat of new entrants – Impact of key factors in 2023 and 2028
- Threat of substitutes
  - Table Threat of substitutes – Impact of key factors in 2023 and 2028
- Threat of rivalry
  - Table Threat of rivalry – Impact of key factors in 2023 and 2028
- Market condition
  - Table Chart on Market condition - Five forces 2023 and 2028
Market Segmentation by Type
- Market segments
  - Table Chart on Type - Market share 2023-2028 (%)
  - Table Data Table on Type - Market share 2023-2028 (%)
- Comparison by Type
  - Table Chart on Comparison by Type
  - Table Data Table on Comparison by Type
- Antisense oligonucleotides (ASOs) - Market size and forecast 2023-2028
  - Table Chart on Antisense oligonucleotides (ASOs) - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Antisense oligonucleotides (ASOs) - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Antisense oligonucleotides (ASOs) - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Antisense oligonucleotides (ASOs) - Year-over-year growth 2023-2028 (%)
- RNA interference (RNAi) - Market size and forecast 2023- 2028
  - Table Chart on RNA interference (RNAi) - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on RNA interference (RNAi) - Market size and forecast 2023-2028 ($ million)
  - Table Chart on RNA interference (RNAi) - Year-over-year growth 2023-2028 (%)
  - Table Data Table on RNA interference (RNAi) - Year-over-year growth 2023-2028 (%)
- Aptamers and others - Market size and forecast 2023- 2028
  - Table Chart on Aptamers and others - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Aptamers and others - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Aptamers and others - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Aptamers and others - Year-over-year growth 2023-2028 (%)
- Market opportunity by Type
  - Table Market opportunity by Type ($ million)
  - Table Data Table on Market opportunity by Type ($ million)
Market Segmentation by Application
- Market segments
  - Table Chart on Application - Market share 2023-2028 (%)
  - Table Data Table on Application - Market share 2023-2028 (%)
- Comparison by Application
  - Table Chart on Comparison by Application
  - Table Data Table on Comparison by Application
- Neurological - Market size and forecast 2023-2028
  - Table Chart on Neurological - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Neurological - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Neurological - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Neurological - Year-over-year growth 2023-2028 (%)
- Cancer - Market size and forecast 2023-2028
  - Table Chart on Cancer - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Cancer - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Cancer - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Cancer - Year-over-year growth 2023-2028 (%)
- Infectious diseases and others - Market size and forecast 2023-2028
  - Table Chart on Infectious diseases and others - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Infectious diseases and others - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Infectious diseases and others - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Infectious diseases and others - Year-over-year growth 2023-2028 (%)
- Market opportunity by Application
  - Table Market opportunity by Application ($ million)
  - Table Data Table on Market opportunity by Application ($ million)
Customer Landscape
- Customer landscape overview
  - Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Geographic Landscape
- Geographic segmentation
  - Table Chart on Market share by geography 2023-2028 (%)
  - Table Data Table on Market share by geography 2023-2028 (%)
- Geographic comparison
  - Table Chart on Geographic comparison
  - Table Data Table on Geographic comparison
- North America - Market size and forecast 2023-2028
  - Table Chart on North America - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on North America - Market size and forecast 2023-2028 ($ million)
  - Table Chart on North America - Year-over-year growth 2023-2028 (%)
  - Table Data Table on North America - Year-over-year growth 2023-2028 (%)
- Europe - Market size and forecast 2023-2028
  - Table Chart on Europe - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Europe - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Europe - Year-over-year growth 2023-2028 (%)
- Asia - Market size and forecast 2023-2028
  - Table Chart on Asia - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Asia - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Asia - Year-over-year growth 2023-2028 (%)
- Rest of World (ROW) - Market size and forecast 2023- 2028
  - Table Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- US - Market size and forecast 2023-2028
  - Table Chart on US - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on US - Market size and forecast 2023-2028 ($ million)
  - Table Chart on US - Year-over-year growth 2023-2028 (%)
  - Table Data Table on US - Year-over-year growth 2023-2028 (%)
- UK - Market size and forecast 2023-2028
  - Table Chart on UK - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on UK - Market size and forecast 2023-2028 ($ million)
  - Table Chart on UK - Year-over-year growth 2023-2028 (%)
  - Table Data Table on UK - Year-over-year growth 2023-2028 (%)
- Germany - Market size and forecast 2023-2028
  - Table Chart on Germany - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Germany - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Germany - Year-over-year growth 2023-2028 (%)
- Canada - Market size and forecast 2023-2028
  - Table Chart on Canada - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Canada - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Canada - Year-over-year growth 2023-2028 (%)
- Japan - Market size and forecast 2023-2028
  - Table Chart on Japan - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Japan - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Japan - Year-over-year growth 2023-2028 (%)
- Market opportunity by geography
  - Table Market opportunity by geography ($ million)
  - Table Data Tables on Market opportunity by geography ($ million)
Drivers, Challenges, and Trends
- Market drivers
  - Increasing incidence of cancer boosts demand for novel diagnostics
  - Need for personalized medicines for neurological disorders
  - Increasing availability of oligonucleotide therapeutic drugs
- Market challenges
  - Inherent issues associated with oligonucleotide therapies
  - Stringent regulatory guidelines on approval of neuromuscular drugs
  - Toxicity and instability of ASO and RNAi molecule-based drugs
- Impact of drivers and challenges
  - Table Impact of drivers and challenges in 2023 and 2028
- Market trends
  - Advances in DNA sequencing increasing adoption of microfluidic techniques
  - High market growth potential in developing economies
  - Growing adoption of artificial intelligence for disease evaluation
Vendor Landscape
- Overview
- Vendor landscape
  - Table Overview on Criticality of inputs and Factors of differentiation
- Landscape disruption
  - Table Overview on factors of disruption
- Industry risks
  - Table Impact of key risks on business
Vendor Analysis
- Vendors covered
  - Table Vendors covered
- Market positioning of vendors
  - Table Matrix on vendor position and classification
- Agilent Technologies Inc.
  - Table Agilent Technologies Inc. - Overview
  - Table Agilent Technologies Inc. - Business segments
  - Table Agilent Technologies Inc. - Key news
  - Table Agilent Technologies Inc. - Key offerings
  - Table Agilent Technologies Inc. - Segment focus
- Alnylam Pharmaceuticals Inc.
  - Table Alnylam Pharmaceuticals Inc. - Overview
  - Table Alnylam Pharmaceuticals Inc. - Product / Service
  - Table Alnylam Pharmaceuticals Inc. - Key offerings
- Biogen Inc.
  - Table Biogen Inc. - Overview
  - Table Biogen Inc. - Product / Service
  - Table Biogen Inc. - Key news
  - Table Biogen Inc. - Key offerings
- CSL Ltd.
  - Table CSL Ltd. - Overview
  - Table CSL Ltd. - Business segments
  - Table CSL Ltd. - Key news
  - Table CSL Ltd. - Key offerings
  - Table CSL Ltd. - Segment focus
- GlaxoSmithKline Plc
  - Table GlaxoSmithKline Plc - Overview
  - Table GlaxoSmithKline Plc - Business segments
  - Table GlaxoSmithKline Plc - Key news
  - Table GlaxoSmithKline Plc - Key offerings
  - Table GlaxoSmithKline Plc - Segment focus
- Ionis Pharmaceuticals Inc.
  - Table Ionis Pharmaceuticals Inc. - Overview
  - Table Ionis Pharmaceuticals Inc. - Business segments
  - Table Ionis Pharmaceuticals Inc. - Key offerings
  - Table Ionis Pharmaceuticals Inc. - Segment focus
- Maravai LifeSciences Holdings Inc.
  - Table Maravai LifeSciences Holdings Inc. - Overview
  - Table Maravai LifeSciences Holdings Inc. - Business segments
  - Table Maravai LifeSciences Holdings Inc. - Key offerings
  - Table Maravai LifeSciences Holdings Inc. - Segment focus
- Merck KGaA
  - Table Merck KGaA - Overview
  - Table Merck KGaA - Business segments
  - Table Merck KGaA - Key news
  - Table Merck KGaA - Key offerings
  - Table Merck KGaA - Segment focus
- Nippon Shinyaku Co. Ltd.
  - Table Nippon Shinyaku Co. Ltd. - Overview
  - Table Nippon Shinyaku Co. Ltd. - Business segments
  - Table Nippon Shinyaku Co. Ltd. - Key offerings
  - Table Nippon Shinyaku Co. Ltd. - Segment focus
- Novartis AG
  - Table Novartis AG - Overview
  - Table Novartis AG - Business segments
  - Table Novartis AG - Key news
  - Table Novartis AG - Key offerings
  - Table Novartis AG - Segment focus
- Pfizer Inc.
  - Table Pfizer Inc. - Overview
  - Table Pfizer Inc. - Product / Service
  - Table Pfizer Inc. - Key news
  - Table Pfizer Inc. - Key offerings
- Sarepta Therapeutics Inc.
  - Table Sarepta Therapeutics Inc. - Overview
  - Table Sarepta Therapeutics Inc. - Product / Service
  - Table Sarepta Therapeutics Inc. - Key offerings
- Thermo Fisher Scientific Inc.
  - Table Thermo Fisher Scientific Inc. - Overview
  - Table Thermo Fisher Scientific Inc. - Business segments
  - Table Thermo Fisher Scientific Inc. - Key news
  - Table Thermo Fisher Scientific Inc. - Key offerings
  - Table Thermo Fisher Scientific Inc. - Segment focus
Appendix
- Scope of the report
  - Market definition
  - Objectives
  - Notes and caveats
- Inclusions and exclusions checklist
  - Table Inclusions checklist
  - Table Exclusions checklist
- Currency conversion rates for US$
  - Table Currency conversion rates for US$
- Research methodology
  - Table Research methodology
  - Table Validation techniques employed for market sizing
  - Table Information sources
- List of abbreviations
  - Table List of abbreviations